Status:
UNKNOWN
Tolerance of Anti-Cancer Therapy in the Elderly
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Conditions:
Frailty
Chemotherapeutic Toxicity
Eligibility:
All Genders
65+ years
Brief Summary
This is a multicentre observational study evaluating frailty and tolerance of chemotherapy in the elderly.
Detailed Description
This is a multicentre observational study evaluating frailty and tolerance of chemotherapy in the elderly. The number of people with cancer over the age of 65 years is increasing and more older patie...
Eligibility Criteria
Inclusion
- Age \>65years
- About to start first line chemotherapy for a solid tumour based malignancy
- Chemotherapy given for any intent eg. adjuvant or palliative
- Estimated survival of \>3months
- Able to comprehend and complete questionnaire.
Exclusion
- Medical or psychiatric condition impairing ability to consent
- Participant is enrolled in another clinical trial
- Prior chemotherapy for any indication
- Receiving concurrent radiotherapy (RT) or immunotherapy (IT)
- Unable to provide informed consent
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05251922
Start Date
November 1 2020
End Date
June 1 2023
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds NHS Teaching Hospitals
Leeds, United Kingdom